Ostrom R S, Ehlert F J
Department of Pharmacology, College of Medicine, University of California, Irvine, USA.
J Pharmacol Exp Ther. 1998 Jul;286(1):234-42.
The ability of the M2 muscarinic receptor to inhibit the relaxant effects of forskolin and isoproterenol was investigated in bovine trachea. In most experiments, we measured contractile responses to oxotremorine-M in smooth muscle isolated from bovine trachea in which a majority of M3 receptors were inactivated by treatment with N-(2-chloroethyl)-4-piperidinyl diphenylacetate. In the presence of histamine (20 microM), the histamine H2 antagonist cimetidine (10 microM) and forskolin (4 microM), responses to oxotremorine-M were antagonized by [[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5, 11-dihydro-6H-pyrido[2,3b][1,4]benzodiazepine-6-one (1 microM) in a manner consistent with contractions mediated predominantly by M2 receptors. When similar experiments were conducted in the presence of isoproterenol (0.1 microM) instead of forskolin, contractions were antagonized in a manner consistent with an M3 receptor-mediated response. In similar experiments, we measured the relaxant potency of isoproterenol and forskolin against histamine-induced contractions in N-(2-chloroethyl)-4-piperidinyl diphenylacetate-treated trachea. By itself, oxotremorine-M (7.5 nM) had no contractile effect; however, it caused a substantial reduction in the relaxant potency of forskolin although having little effect on that of isoproterenol. These experiments establish that M2 receptors inhibit the relaxant effects of forskolin, but not isoproterenol. In untreated tissues, the relaxant responses to isoproterenol and forskolin were 10.8- and 14.2-fold more potent, respectively, against histamine than against oxotremorine-M-induced contractions of equal magnitude. Similarly, the maximal stimulation of cAMP accumulation elicited by isoproterenol and forskolin was inhibited 58 and 62%, respectively, in the presence of oxotremorine-M (80 nM) compared to that measured in the presence of histamine (20 microM). Analysis of the data indicated that isoproterenol elicited relaxation at concentrations well beyond those that stimulated maximal levels of cAMP accumulation. Our results indicate that part of the relaxant response to isoproterenol is mediated through a non-cAMP-dependent mechanism, and that this mechanism is largely unopposed by the M2 receptor.
在牛气管中研究了M2毒蕈碱受体抑制福斯可林和异丙肾上腺素舒张作用的能力。在大多数实验中,我们测量了从牛气管分离的平滑肌对氧化震颤素-M的收缩反应,其中大部分M3受体通过用N-(2-氯乙基)-4-哌啶基二苯乙酸酯处理而失活。在组胺(20微摩尔)、组胺H2拮抗剂西咪替丁(10微摩尔)和福斯可林(4微摩尔)存在的情况下,[[2-[(二乙氨基)甲基]-1-哌啶基]乙酰基]-5,11-二氢-6H-吡啶并[2,3b][1,4]苯二氮䓬-6-酮(1微摩尔)以与主要由M2受体介导的收缩一致的方式拮抗对氧化震颤素-M的反应。当在存在异丙肾上腺素(0.1微摩尔)而不是福斯可林的情况下进行类似实验时,收缩以与M3受体介导的反应一致的方式被拮抗。在类似实验中,我们测量了异丙肾上腺素和福斯可林对N-(2-氯乙基)-4-哌啶基二苯乙酸酯处理的气管中组胺诱导的收缩的舒张效力。氧化震颤素-M(7.5纳摩尔)本身没有收缩作用;然而,它虽然对异丙肾上腺素的舒张效力影响很小,但却导致福斯可林的舒张效力大幅降低。这些实验表明M2受体抑制福斯可林的舒张作用,但不抑制异丙肾上腺素的舒张作用。在未处理的组织中,对异丙肾上腺素和福斯可林的舒张反应分别比对组胺的反应强10.8倍和14.2倍,而组胺引起的收缩幅度与氧化震颤素-M引起的收缩幅度相同。同样,与在组胺(20微摩尔)存在下测量的值相比,在氧化震颤素-M(80纳摩尔)存在下,异丙肾上腺素和福斯可林引起的cAMP积累的最大刺激分别被抑制了58%和62%。数据分析表明,异丙肾上腺素在远远超过刺激最大cAMP积累水平的浓度下引起舒张。我们的结果表明,对异丙肾上腺素的部分舒张反应是通过非cAMP依赖性机制介导的,并且该机制在很大程度上不受M2受体的对抗。